Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$525.28 USD

525.28
842,078

-0.66 (-0.13%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $525.55 +0.27 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

MCK vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. COO: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Amgen, Cisco, Berkshire Hathaway, T. Rowe Price and McKesson

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Amgen, Cisco, Berkshire Hathaway, T. Rowe Price and McKesson

Mark Vickery headshot

Top Research Reports for Amgen, Cisco & Berkshire Hathaway

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Amgen (AMGN), Cisco (CSCO) and Berkshire Hathaway (BRK.B).

Are Investors Undervaluing McKesson (MCK) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Looking for Value? Why It Might Be Time to Try McKesson (MCK)

by Zacks Equity Research

McKesson (MCK) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

MCK vs. ALGN: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. ALGN: Which Stock Is the Better Value Option?

McKesson (MCK) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Should Value Investors Consider McKesson (MCK) Stock Now?

by Zacks Equity Research

Let's see if McKesson (MCK) stock is a good choice for value-oriented investors right now from multiple angles.

Here's Why You Should Hold on to McKesson (MCK) Stock Now

by Zacks Equity Research

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.

Is McKesson (MCK) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MCK vs. WST: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. WST: Which Stock Is the Better Value Option?

McKesson (MCK) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

McKesson's (MCK) Q1 results benefit from higher revenues and solid show by U.S. Pharmaceutical and Specialty, and Medical-Surgical Solutions.

McKesson (MCK) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

McKesson (MCK) delivered earnings and revenue surprises of 8.88% and 3.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Medical Products' Earnings Roster for Jul 31: MCK, HOLX & More

by Zacks Equity Research

Solid growth in emerging markets is expected to be an added positive this earnings season.

Top Ranked Value Stocks to Buy for July 26th

by Zacks Equity Research

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 26th

McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MCK vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. COO: Which Stock Is the Better Value Option?

Is McKesson (MCK) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why the Earnings Surprise Streak Could Continue for McKesson (MCK)

by Zacks Equity Research

McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

McKesson (MCK) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.

Can Instruments Drive Intuitive Surgical (ISRG) Q2 Earnings?

by Zacks Equity Research

Intuitive Surgical (ISRG) expects its core Instruments and Accessories unit to boost second-quarter 2019 results.

Rite Aid Expands in Northeast With Thrifty Ice Cream Brand

by Zacks Equity Research

Rite Aid (RAD) expands the availability of its Thrifty Ice Cream brand in select stores in Delaware, New York, Maryland, New Jersey and Pennsylvania.

Here's Why You Should Hold on to McKesson (MCK) Stock Now

by Zacks Equity Research

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market.

QIAGEN Inks Distribution Deal With Mckesson Medical-Surgical

by Zacks Equity Research

The distribution agreement will enable QIAGEN (QGEN) to expand reach in the healthcare market.